Moderate

Epilepsy in pregnancy

Epilepsy · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Pregnancy in women with epilepsy requires balancing seizure control against teratogenic risk of antiepileptic drugs. Preconception optimisation, high-dose folic acid and avoidance of sodium valproate are central.

Red flags

  • Status epilepticus
  • New-onset seizures in the second half of pregnancy (consider eclampsia)
  • Deteriorating seizure control
  • Poor medication adherence
  • Signs of drug toxicity

Assessment

Differential diagnosis

  • Known epilepsy on treatment
  • Eclampsia (new seizures in late pregnancy)
  • Gestational exacerbation of seizures
  • Non-epileptic attack disorder
  • Other causes of seizures (infection, hypoglycaemia)

Investigations

  • Review seizure type, frequency and current medication
  • Antiepileptic drug levels where clinically indicated (e.g. lamotrigine)
  • Detailed anomaly scan and fetal cardiac assessment
  • BP and urinalysis to distinguish from eclampsia if late seizures
  • Fetal growth monitoring

Management

  • Provide preconception counselling and optimise to monotherapy at the lowest effective dose
  • Prescribe folic acid 5 mg daily before conception and through the first trimester
  • Avoid sodium valproate in women of childbearing potential unless no alternative and within a pregnancy prevention programme
  • Prefer lamotrigine or levetiracetam where seizure type permits
  • Do not stop antiepileptic drugs abruptly because of seizure and status risk
  • Monitor drug levels and adjust dose for levels that fall in pregnancy (notably lamotrigine)
  • Offer vitamin K to the neonate and counsel on safe infant care (avoid co-sleeping, safe bathing)
  • Plan birth in an obstetric unit with a seizure management plan
  • Review medication and doses postnatally as levels change, and support breastfeeding which is generally safe

Drugs & doses

Folic acid 5 mg PO once daily preconception and first trimester
Lamotrigine or levetiracetam as preferred antiepileptics, dose titrated to levels
Avoid sodium valproate in those able to become pregnant
Lorazepam 4 mg IV or buccal midazolam 10 mg for acute seizures in labour

Disposition

Joint neurology and obstetric (maternal medicine) care; deliver in an obstetric unit with a documented seizure plan; emergency treatment for status epilepticus.

Complications & pitfalls

  • Congenital malformations (highest with valproate)
  • Neurodevelopmental impairment
  • Sudden unexpected death in epilepsy
  • Seizure-related maternal and fetal injury
  • Status epilepticus

Exam pearls

  • Most women with epilepsy have uncomplicated pregnancies on appropriate treatment
  • Never stop antiepileptics abruptly to avoid harm
  • Lamotrigine levels fall substantially in pregnancy and often need upward adjustment
  • Valproate carries a roughly 10% malformation and 30-40% neurodevelopmental risk and must be avoided where possible

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.